A discreet consultation can help clarify a breast change and the next step. Illustrative photograph, not a diagnosis or an image of a clinic client.
A change in breast size or tenderness can be difficult to raise in a consultation. Gynaecomastia, enlargement of glandular breast tissue in men, is common and usually benign. It can affect one or both sides, and the two sides do not always look the same. The purpose of assessment is to establish what has changed and whether there is a cause that needs attention.
A new breast lump should not be labelled gynaecomastia from a photograph or an online description. Nipple discharge, skin changes, a new inverted nipple or a lump in the armpit also deserve a GP assessment. Most such symptoms do not turn out to be cancer, but a reassuring explanation should follow an examination rather than replace it.
Which breast changes should be checked?
The NHS advises seeing a GP for a breast or nipple lump, persistent breast or nipple pain, skin changes, or discharge or bleeding from the nipple. A change in the appearance of the chest can also be a reason to seek advice, even if it is not painful. There is no need to wait until embarrassment or discomfort becomes severe.
A distinct lump, bloody discharge, nipple ulceration or distortion can change the referral route. These features should be described when arranging the assessment. A clinician may recommend an urgent breast specialist review if the findings are concerning. An urgent referral means the cause needs clarification, not that cancer has already been diagnosed.
An existing diagnosis of gynaecomastia does not explain every future change. New discharge, a different lump, skin changes or increasing symptoms need reassessment. Likewise, having symptoms on both sides does not make an examination unnecessary, and one-sided enlargement is not automatically cancer.
What is gynaecomastia?
True gynaecomastia involves an increase in glandular breast tissue. It is often felt beneath the nipple and may be tender. It can occur during puberty, later adulthood or at other times. The NHS describes it as common and often harmless, although an underlying condition or medicine can sometimes contribute.
This is different from an increase in fatty tissue in the chest, sometimes called pseudo-gynaecomastia. Both can be present together. The distinction matters because a change in body weight, a glandular change and a separate breast lump are not the same problem and do not all need the same response.
A clinical examination helps make that distinction. Self-examination or photographs may show that something has changed, but they cannot reliably identify the type of tissue or exclude another cause. The aim is a clear explanation based on the individual's findings, not a label based only on body shape.
Why can hormone changes affect breast tissue?
The balance between the effects of oestrogen and testosterone can influence breast tissue. During puberty, temporary hormone changes can lead to tenderness or enlargement. Later in life, changes in hormone production and body composition can also contribute. These are recognised patterns, but age alone should not be used to dismiss a new symptom.
Gynaecomastia does not automatically mean someone has a low testosterone level that needs replacement. Hormone results, symptoms and examination have to be interpreted together. Starting testosterone, an anti-oestrogen or an unregulated supplement before assessment can obscure the picture and expose someone to unnecessary treatment.
The useful clinical question is why the change has happened in this person. Sometimes there is a clear physiological or medicine-related explanation. Sometimes further investigation is appropriate. In other cases no single cause is identified, but that conclusion should come from an assessment rather than an assumption.
How is puberty-related enlargement approached?
Breast enlargement during puberty commonly settles over time. The NHS notes that treatment may not be needed. Nevertheless, a consultation can be useful when the change is painful, marked, persistent or worrying. A young person's distress deserves attention even when the eventual explanation is a normal stage of development.
The clinician considers the timing of puberty, the pattern of enlargement and any other symptoms. The assessment is not simply an adult treatment plan applied to a younger person. Tests, specialist advice or observation are chosen according to the findings and the clinical situation.
Reassurance should include a plan for what to do if the tissue changes further, pain persists or another symptom develops. It should not amount to a promise that the chest will look a particular way by a fixed birthday. The pace of change varies, and follow-up can be appropriate when concerns remain.
What role do weight and body composition play?
Weight gain can increase fatty tissue in the chest, and body fat also has hormonal effects. A clinician may therefore discuss body composition as part of the overall picture. That discussion should be respectful and should not replace an examination of a new lump or nipple change.
Where excess fatty tissue contributes, a sustainable approach to weight may help. However, weight loss does not necessarily remove established glandular tissue. It is unhelpful to promise that every form of breast enlargement can be corrected through exercise, or to imply that the person has caused the problem by not training hard enough.
The distinction also helps set realistic goals. A person can be lean and have gynaecomastia, or have a mixture of glandular and fatty tissue. A treatment discussion should reflect that finding rather than starting with a generic diet or cosmetic programme before the cause has been considered.
Can prescribed medicines contribute?
Some prescribed medicines can be associated with gynaecomastia. The assessment includes a review of current treatment, when it began and whether a dose or medicine changed before the breast symptoms appeared. Medicines used for several different conditions may be relevant, so a complete list is more useful than guessing which tablet is responsible.
Do not stop an important medicine on the basis of an article or a suspected association. The benefit of the original treatment, the likelihood that it contributed and the availability of alternatives need to be weighed together. A prescribing clinician can explain whether a change is safe and worthwhile.
Even when a medicine is involved, established tissue may not disappear completely after treatment is changed. The response can depend on the duration and nature of the enlargement. A realistic review separates preventing further change, reducing tenderness and reducing tissue size rather than treating them as a guaranteed single outcome.
Why are supplements, anabolic steroids and alcohol discussed?
The NHS includes anabolic steroid use among possible causes of gynaecomastia. Other substances, supplements and alcohol can also be relevant to the history. A discreet consultation should make it possible to discuss these without judgement, because the information can affect both the diagnosis and the safety of any proposed treatment.
A product described as natural, a gym supplement or an online hormone aid should still be included in the medicine history. The clinician needs the actual product and ingredient information where available. A label's promise about hormone balance is not evidence that the product is appropriate or harmless.
Trying to counter a suspected steroid effect with another unprescribed hormone is not a safe substitute for assessment. The next step may involve medical advice about the substance as well as investigation of the breast change. No one should have to manage a confusing mixture of products without a clear clinical review.
Which underlying conditions may be considered?
Gynaecomastia can sometimes occur with thyroid, liver or kidney disease, or conditions affecting testicular function and hormone balance. These are possibilities to assess, not a list of diagnoses implied by the symptom. The clinician looks for relevant history and examination findings rather than ordering every possible test for everyone.
Other symptoms can help guide the discussion. Changes in sexual function, libido, testicular symptoms or general health may be relevant. A rapidly developing change also needs its own assessment. It is important to mention these details even if they do not initially seem connected to the breast concern.
Finding an underlying condition can change treatment priorities. Addressing that condition may help the breast symptoms, but improvement cannot be promised in advance. Sometimes the breast finding and another medical issue need parallel care rather than assuming one treatment will settle every concern.
What happens during the consultation?
The history covers when the change started, whether it is progressing, pain or tenderness, discharge and changes in the skin or nipple. Current medicines, supplements, relevant illnesses and family history can help establish the context. The effect on confidence, daily life and relationships is also a valid part of the consultation.
The chest and breast tissue may need examination to distinguish general enlargement from a separate lump. The clinician may assess the armpits and other areas when appropriate. A broader examination can include the thyroid, abdomen or testicles if the findings and history indicate that these may be relevant.
An intimate examination should be explained so the person understands its purpose. It is reasonable to discuss a chaperone or support person when arranging or attending an examination. A remote discussion may help establish the history, but it cannot replace a physical assessment when the nature of a lump is uncertain.
When are blood tests useful?
Blood tests are selected according to the suspected cause. They may include liver, kidney or thyroid function and, in some circumstances, hormone tests. Some clinical pathways also include tests that investigate less common causes. A test should have a clear purpose rather than being sold as a universal hormone panel for all breast enlargement.
The timing and interpretation of hormone samples can matter. A single result should not automatically become a diagnosis or a prescription. Symptoms, medicines, examination and related results may all affect what the finding means and whether it needs repeating or specialist review.
Blood tests do not rule out every breast problem. If a lump or other concerning feature needs a breast specialist assessment, that referral should not be delayed while waiting for a broad set of results. The investigation route follows the clinical concern, not a fixed sequence that everyone must complete first.
Does everyone need breast imaging?
No. Imaging is not automatically needed when an examination clearly supports uncomplicated gynaecomastia. A distinct lump or uncertainty can lead to further assessment. A breast specialist may recommend a mammogram, ultrasound or a tissue sample depending on the clinical findings and the question that needs answering.
Scottish NHS guidance distinguishes generalised glandular enlargement from a specific breast lump. It also notes that many cases can be managed without secondary care investigations. This is useful clinical context, not a promise that a London clinic follows an identical local pathway or can provide every investigation on site.
A scan should not be arranged simply to avoid discussing or examining the symptom. Equally, a reassuring blood test does not make indicated imaging unnecessary. When several investigations are proposed, the value lies in how they fit together to establish the diagnosis and guide the next step.
What treatment may be appropriate?
Once the diagnosis is clear, observation and reassurance may be enough. If there is an underlying condition or a contributing medicine, management can focus on that. Weight management may help when fatty tissue is part of the picture. The plan should explain what improvement is realistic and when further review is appropriate.
Medicines are sometimes considered for selected cases, usually with specialist input. Some uses are outside the medicine's licensed indication, and benefits, side effects and follow-up need discussion. This is not a reason to buy tamoxifen or an aromatase inhibitor online or use another person's prescription.
Published pathways differ in prescribing and funding arrangements. Their medicine lists and doses are not a self-treatment protocol or evidence of what this clinic provides. A recommendation should be based on the diagnosis, duration, symptoms and individual risks rather than on the fact that a drug is mentioned in a patient information page.
When might surgery be discussed?
Surgery can reduce breast tissue in selected circumstances, particularly when enlargement persists and has a substantial physical or psychological impact. It is not the first answer to every new breast change. A clear diagnosis and consideration of any continuing cause come before a cosmetic treatment decision.
The operation depends on the type and amount of tissue and skin involved. It can involve removal of glandular tissue, fat or both, and may leave scars. A specialist discussion should cover likely appearance, recovery, risks, limitations and the possibility of further treatment without guaranteeing a particular result.
Availability and funding vary, and surgery for appearance alone may not be available through the NHS. An online article cannot confirm eligibility or a price. The Online GP enquiry route is for assessment of the concern, not a promise of breast reduction surgery or an agreed surgical referral package.
What does follow-up need to cover?
Follow-up may review pain, the size or character of the tissue and the effect of any change in treatment. It can also revisit the impact on daily life. A person who is reassured about cancer may still need help with persistent tenderness or distress, and those concerns should not be dismissed as trivial.
The plan should make clear which changes require another assessment. A new distinct lump, nipple discharge, skin or nipple change, or continuing enlargement should be reported even after an earlier benign diagnosis. New symptoms should be judged on their current features rather than assumed to be part of the old finding.
A careful explanation can reduce uncertainty without making promises that cannot be kept. The aim is to understand the cause, choose an appropriate response and provide a clear route back if the situation changes. That is different from either investigating every possible diagnosis or offering reassurance without examining the concern.
Arranging an assessment with The Online GP
The Online GP by The Wellness can receive an enquiry about breast enlargement, tenderness or a change in the chest. Describe the duration, whether one or both sides are affected, any distinct lump, discharge or skin change, and relevant medicines or supplements. The team can clarify the appropriate assessment route.
An enquiry does not establish a diagnosis or confirm a scan, hormone prescription, specialist appointment or procedure. Some concerns need an in-person examination or prompt specialist assessment. If a new lump or nipple change is present, explain that clearly rather than requesting only a cosmetic treatment discussion.
Discuss breast enlargement or a change in the chest with The Wellness
Frequently asked questions
Is gynaecomastia cancer?
Gynaecomastia is a benign enlargement of glandular breast tissue. However, a new lump or nipple change should not be assumed to be gynaecomastia without assessment. The NHS advises a GP review for a lump, discharge or an unfamiliar change in the chest or nipple.
Can it affect only one side?
Yes. One or both sides can be affected, and enlargement may be uneven. That does not establish the diagnosis or exclude another cause. A clinician should assess a new or changing one-sided finding, particularly if there is a separate lump, discharge or skin change.
Does breast enlargement mean I need testosterone?
No. There are several possible causes, including normal life-stage changes, medicines and other conditions. Hormone tests are interpreted with the history and examination. Testosterone or another hormone treatment should not be started simply because breast tissue has enlarged.
Will losing weight remove it?
Weight management may help when fatty tissue contributes, but it does not necessarily remove glandular tissue. Some people have a mixture of both. Assessment helps set realistic expectations and avoids delaying a review of a new lump by treating the concern only as a weight issue.
Should I stop a medicine that might be responsible?
Do not stop prescribed treatment without speaking to the prescribing clinician. The original benefit, the suspected link and the safety of alternatives need review. A medicine change may not completely reverse established tissue, so the likely outcome should also be discussed.
What changes need another appointment after a benign diagnosis?
Return for assessment if you develop a new lump, nipple discharge, skin or nipple changes, increasing tissue or persistent pain. A previous diagnosis does not explain every later change. An urgent specialist referral may sometimes be appropriate, but it does not itself mean cancer has been diagnosed.
Sources
NHS, Symptoms of breast cancer in men
NHS Right Decisions, Gynaecomastia pathway
Bromley and colleagues, Gynaecomastia: when and why to refer to specialist care